Loading...
Market
What will be the public perception of AI's impact on longevity science by end of 2025?
1
Resolution / Starting Odds
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Surveys or studies published by reputable organizations or research institutions
Story
OpenAI and Retro Biosciences Use GPT-4b Micro to Enhance Longevity Science by Re-engineering Yamanaka Factors
Jan 17, 2025, 06:37 PM
OpenAI has collaborated with Retro Biosciences to develop an AI model named GPT-4b micro, aimed at enhancing longevity science. The model focuses on re-engineering Yamanaka factors, a set of proteins crucial for converting regular cells into stem cells. This collaboration, which began about a year ago, is part of Retro's broader goal to extend the human lifespan by a decade. The model has been used to suggest modifications to the Yamanaka factors, resulting in versions that are reportedly more than 50 times as effective in cellular reprogramming. OpenAI's CEO, Sam Altman, who personally invested $180 million in Retro in 2022, did not directly participate in the project. The companies plan to publish their research findings, although the model remains a demonstration rather than a product available for public use.
View original story
Similar markets
No significant change • 25%
Decreased concern • 25%
Increased concern • 25%
Mixed opinions • 25%
Neutral • 25%
Positive • 25%
No Significant Change • 25%
Negative • 25%
Majority Acceptable • 25%
Evenly Divided • 25%
Majority Unacceptable • 25%
No Clear Consensus • 25%
Improved perception • 25%
Mixed views • 25%
No change • 25%
Worsened perception • 25%
Widely accepted and positive • 25%
Largely indifferent • 25%
Skeptical or negative • 25%
Cautiously optimistic • 25%
Uncertain • 25%
Improved • 25%
Unchanged • 25%
Worsened • 25%
Indifferent • 25%
Mostly opposed • 25%
Mostly supportive • 25%
Other opinions • 25%
Worsened perception • 25%
Mixed opinions • 25%
Improved perception • 25%
Unchanged perception • 25%
Mixed • 25%
Neutral • 25%
Negative • 25%
Positive • 25%
Significant negative impact • 25%
Moderate negative impact • 25%
No significant impact • 25%
Improved reputation • 25%
Mixed • 25%
Mostly Positive • 25%
Neutral • 25%
Mostly Negative • 25%
Accuracy of replication • 25%
Job displacement • 25%
Ethical concerns • 25%
Privacy issues • 25%